Pacific Biosciences of California (NASDAQ: PACB) — Perfil da empresa, notícias e dados financeiros
Pacific Biosciences develops advanced sequencing technologies, empowering genomic research for human health and science.
Pacific Biosciences of California
Pacific Biosciences of California (NASDAQ:PACB) specializes in developing and manufacturing advanced sequencing technologies that empower scientists and researchers around the world to tackle genetically complex problems. Their standout product suite includes highly accurate long-read sequencing platforms, designed to facilitate the study of human, plant, and animal genomes and drive the discovery of novel insights in genetics. At the heart of their mission is the objective to enable the advancement of science and improve human health through innovation in DNA sequencing. With projects ranging from enhancing genomic research capabilities to partnerships aimed at solving specific scientific challenges, Pacific Biosciences is committed to pushing the boundaries of what's possible in genomics research and applications, tailoring their approach to meet the expanding needs of their global user community.
Resumo
Operações
Produtos e/ou serviços de Pacific Biosciences of California
- Sequel IIe System, enabling highly accurate long-read sequencing for genomics research.
- HiFi sequencing, offering high-fidelity, long-read sequencing capabilities for genomic studies.
- SMRT Link, a comprehensive software suite for sequencing data analysis and management.
- Revio system, designed to significantly increase throughput and reduce costs for long-read genomic sequencing.
- Onso, a new, highly accurate, long-read sequencing platform targeting clinical research applications.
- SMRTbell Express Template Prep Kit 2.0, simplifying library preparation process for genomic sequencing.
equipe executiva do Pacific Biosciences of California
- Mark Van OeneCEO, President & Director
- James R. Gibson IICFO & Principal Accounting Officer
- Christian O. HenrySenior Business Advisor & Director
- Stephen TurnerCo-Founder
- Brett AtkinsGeneral Counsel & Corporate Secretary
- Natalie WelchChief People Officer
Principais indicadores financeiros
Resultados divulgados pela Pacific Biosciences of California, em USD.
- Cap. de mercado
- 761,5 mi
- Receita (TTM)
- 159,3 mi
- P/L
- —
- LPA (diluído, TTM)
- -0.5
- Dividend yield
- —
- Margem de lucro
- -82.5%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 160 mi | -557,6 mi | -546,4 mi | |
| 154 mi | -474,3 mi | -309,9 mi | |
| 200,5 mi | -334,5 mi | -306,7 mi | |
| 128,3 mi | -307,2 mi | -314,2 mi |